etabolic syndrome (MS) is characterized by a cluster of risk factors that increase the chance of cardiovascular disease (CVD). They include: glucose intolerance; hypertension; abdominal obesity; and dyslipidemia. 1 The World Health Organization (WHO) and the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III have separately proposed criteria for the clinical diagnosis of MS. 1,2 The WHO defines MS as a condition of insulin resistance and diabetes mellitus (DM) or impaired glucose tolerance with the presence of 2 or more of these components: obesity (body mass index (BMI) ≥30 kg/m 2 and/or waist-to-hip ratio (WHR) >0.9 and >0.85 for men and women, respectively); hypertension (blood pressure ≥140/90 mmHg); dyslipidemia (triglycerides (TG) ≥1. and microalbuminuria (urinary albumin-to-creatinine ratio (ACR) ≥30 g/mg). 1 The NCEP-ATP III criteria differ slightly with those of the WHO. 2 Subjects with type 2 DM (T2DM) show the highest risk of MS and CVD. Therefore understanding any correlation between CVD risk and the number of risk factors in a doseresponsive pattern, or the binary classification of MS or the components of MS, could well differentiate those patients at risk of ischemic heart disease (IHD) from those not at risk. As a result, the purpose of the present study examines the relation between IHD and (1) each component of MS, (2) the number of components of MS and (3) MS itself, in T2DM cases.
Methods
Study SubjectsThe present study was approved by an ethics committee with subjects participating voluntarily. Taiwan has an established cohort of 93,484 confirmed diabetic patients derived from a national sample of 256,036 patients under National Health Insurance cover, which covers over 96% of the total population. 3,4 A health examination was planned for recruiting 1,400 patients from the main cluster. At random, 4,164 patients were selected from the main cluster and invited to participate in the health examination. A total of 1,441 patients accepted the invitation to this health examination and 1,420 patients were discovered to have T2DM. Among these T2DM patients, 1,296 patients (604 men and 692 women) had complete medical data for analyses in this present study. The mean age was 62.5±11.7 (14-87) years. All subjects were selected at random, thus a selection bias was not Methods and Results A total of 1,296 (604 men and 692 women) subjects with T2DM aged 62.5±11.7 (14-87) years were studied. MS was defined using the World Health Organization modified criteria and included more than 2 of hypertension, obesity, dyslipidemia and microalbuminuria. IHD was diagnosed through history or ischemic electrocardiogram according to the Minnesota codes. Results showed that MS was present in 76.2% and IHD in 36.3% of the patients, respectively. MS increased with age for both sexes, but there was no difference between men and women in the age groups of <45, 45-54 and 55-64 years. However, the prevalence of MS was significantly higher in women (87.7% vs 78.0%) in the age group ≥65 years. IHD prev...